SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 38 filers reported holding SCPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,025 | -61.0% | 45,790 | -44.1% | 0.00% | – |
| Q2 2023 | $835,101 | -22.2% | 81,953 | -30.7% | 0.00% | – |
| Q1 2023 | $1,073,181 | -23.5% | 118,322 | -39.5% | 0.00% | – |
| Q4 2022 | $1,403,226 | +299.8% | 195,708 | +262.9% | 0.00% | – |
| Q3 2022 | $351,000 | +53.9% | 53,936 | +14.2% | 0.00% | – |
| Q2 2022 | $228,000 | +27.4% | 47,234 | +50.0% | 0.00% | – |
| Q1 2022 | $179,000 | -55.1% | 31,494 | -42.0% | 0.00% | – |
| Q2 2020 | $399,000 | +320.0% | 54,277 | +222.5% | 0.00% | – |
| Q2 2018 | $95,000 | – | 16,828 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,561,474 | $17,166,000 | 4.25% |
| AIGH Capital Management LLC | 1,346,724 | $6,491,000 | 1.71% |
| Worth Venture Partners, LLC | 335,985 | $1,784,000 | 1.05% |
| Ikarian Capital, LLC | 884,008 | $4,261,000 | 0.78% |
| Orbimed Advisors | 4,797,148 | $23,122,000 | 0.42% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $13,014,000 | 0.23% |
| Sandy Cove Advisors, LLC | 10,592 | $51,000 | 0.05% |
| Belvedere Trading LLC | 239,219 | $1,270,000 | 0.04% |
| IPG Investment Advisors LLC | 14,300 | $69,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,200 | $637,000 | 0.02% |